Carrier erythrocyte entrapped thymidine phosphorylase therapy for MNGIE

Neurology. 2008 Aug 26;71(9):686-8. doi: 10.1212/01.wnl.0000324602.97205.ab.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Deoxyuridine / urine
  • Drug Delivery Systems
  • Erythrocyte Transfusion / methods*
  • Erythrocytes / enzymology
  • Fatal Outcome
  • Female
  • Gastrointestinal Diseases / drug therapy*
  • Gastrointestinal Diseases / enzymology
  • Gastrointestinal Diseases / physiopathology
  • Genetic Predisposition to Disease / genetics
  • Humans
  • Liver Diseases / drug therapy*
  • Liver Diseases / enzymology
  • Liver Diseases / physiopathology
  • Mitochondrial Diseases / drug therapy*
  • Mitochondrial Diseases / enzymology
  • Mitochondrial Diseases / physiopathology
  • Mutation / genetics
  • Peripheral Nervous System Diseases / drug therapy*
  • Peripheral Nervous System Diseases / enzymology
  • Peripheral Nervous System Diseases / physiopathology
  • Pneumonia / complications
  • Syndrome
  • Thymidine / urine
  • Thymidine Phosphorylase / genetics
  • Thymidine Phosphorylase / therapeutic use*
  • Treatment Failure

Substances

  • Thymidine Phosphorylase
  • Thymidine
  • Deoxyuridine